Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02247908 · ClinicalTrials.gov registry record · NA
Impact of Graphic Cigarette Warnings
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 2,149
- Enrollment target
NCT02247908 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2,149 participants.
The verdict
NCT02247908, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,149 participants
- Enrollment target
Study Summary
The purpose of this randomized controlled trial is to determine whether graphic health warnings on cigarette packs are more effective than the existing Surgeon General's warning on cigarette packs at encouraging quit attempts. While previous experiments evaluating candidate graphic warnings have been informative, they have used psychological outcomes, such as attitudes or quit intentions, but not actual cessation behavior (e.g., quit attempts). Furthermore, they typically expose participants to warnings in controlled but artificial experimental settings for a short period of time, using much lower frequency and shorter duration of warning exposure than found in the real world. This study addresses these issues by evaluating the impact of warnings on quit attempts by randomly assigning smokers to have their cigarette packs labeled with either a graphic warning or a Surgeon General's warning for four weeks. Main hypothesis: Smokers randomized to receive graphic warnings on their cigarette packs will be more likely to report a quit attempt in the 4 weeks of the study than smokers randomized to receive a Surgeon General's label on their cigarette packs. Secondary hypothesis: Smokers randomized to receive graphic warnings on their cigarette packs will have higher quit intentions at 4 weeks than smokers randomized to receive a Surgeon General's label on their cigarette packs, controlling for baseline quit intentions.
Interventions
- OTHER Graphic Warning
- OTHER Surgeon General's Warning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,149 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02247908
The ClinicalTrials.gov registry entry for NCT02247908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Graphic Warning is the first listed.
NCT02247908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02247908 about?
NCT02247908 is a clinical study titled "Impact of Graphic Cigarette Warnings". The purpose of this randomized controlled trial is to determine whether graphic health warnings on cigarette packs are more effective than the existing Surgeon General's warning on cigarette packs at encouraging quit attempts. While previous experiments evaluating candidate graphic warnings have bee...
What is the current status of trial NCT02247908?
This trial is currently completed. It is a NA study. The enrollment target is 2,149 participants. The study started on 2014-10. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02247908?
The interventions under investigation include: Graphic Warning (OTHER), Surgeon General's Warning (OTHER).
Who is sponsoring clinical trial NCT02247908?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.